BIOSIDUS vs Ethris

BIOSIDUS logo

BIOSIDUS

Pioneros y Líderes en Biosimilares en Mercados Emergentes

504 employees · est. 1983 · Argentina

VS
Ethris logo

Ethris

Clinical stage biotech company focused on development of disruptive mRNA therapeutics for severe respiratory diseases

34 employees · est. 2009 · Planegg, Germany

BIOSIDUS is the older company (1983 vs 2009); BIOSIDUS is the larger of the two.

Side-by-Side Comparison

BIOSIDUS Ethris
Founded
1983 older 2009
Headquarters
Argentina Planegg, Germany
Employees
504 larger 34
Industry
Biotechnology, Manufacturing, Pharmaceutical Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Private Equity Venture round
Total Funding
Not tracked yet $84.80M
Funding Rounds
1 8
Services
Research and Development, Pharmacovigilance, Patient Support Programs, Biotechnological Products Development of mRNA therapeutics, Innovative RNA delivery platforms, Collaborative partnerships and licensing, Clinical pipeline advancement
Target Customers
Healthcare Professionals, Patients, Biotechnology Firms, International Distributors Pharmaceutical companies, Biotech firms, Healthcare providers, Patients with respiratory and genetic disorders
Taxonomy
BiologicsBiosimilarsBiopharmaceuticalsPharmaceutical ManufacturingBacterial FermentationCell Culture +7 Messenger RNA TechnologyTherapeutic ProteinsTranscript TherapiesIntegrated PlatformGene TherapyDrug Development +3
Website
biosidus.com.ar ethris.com
BIOSIDUS logo

About BIOSIDUS

BIOSIDUS is an Argentine biotechnology company, distinguished as a pioneer and leader in the biosimilar sector within emerging markets. Established in 1983, the company has spent over two decades building a robust global operation dedicated to the research, development, production, and commercializa...

Ethris logo

About Ethris

Ethris, founded in 2009 and headquartered in Germany, is a pioneering player in the Biopharma, Biotechnology, and Pharmaceutical industries, notably also making strides in Clean Energy. The company is distinguished by its innovative approach to using its proprietary messenger RNA technology platform...

Also comparing in this category

Comparing more than these two?

Get BIOSIDUS, Ethris and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does BIOSIDUS compare?

A PDF of BIOSIDUS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

BIOSIDUS was founded in 1983, based in Argentina, with 504 employees. BIOSIDUS is an Argentine biotechnology company, distinguished as a pioneer and leader in the biosimilar sector within emerging markets. Established in 1983, the company has spent over two decades buil. Ethris was founded in 2009, based in Planegg, Germany, with 34 employees. Ethris, founded in 2009 and headquartered in Germany, is a pioneering player in the Biopharma, Biotechnology, and Pharmaceutical industries, notably also making strides in Clean Energy. The company is.
BIOSIDUS has raised no disclosed funding and Ethris $84.80M. Latest stage: BIOSIDUS Private Equity, Ethris Venture round.
Both work in Biotechnology and Pharmaceutical and list biopharmaceuticals, therapeutic proteins and drug development among their focus areas.

Compare BIOSIDUS with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BIOSIDUS on 16 Mar 2026, and Ethris on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes